Browse > Article

Medications at the End of Life Care for Terminal Cancer Patients during Their Last Admission  

Kim, Do-Yeun (Dongguk University-Seoul, Graduate School of Medicine)
Publication Information
Journal of Hospice and Palliative Care / v.13, no.1, 2010 , pp. 7-12 More about this Journal
Abstract
Purpose: To evaluate medications at the end of life care for terminal cancer patients during their last admission. Methods: Medical records of terminal cancer patients during their last admission from July 2003 to April 2008 at a district academic hospital were evaluated. Patient's characteristics, therapeutic drug classification during their last admission and on the patient's day of death, and the administrated route and number of medications on the patient's day of death were analyzed. Results: Total 81 patients were included. The median patient age was 63 years. The median length of admission was 18 days (range: 1~101). 54% of the patients had more than one comorbidities. The most frequently prescribed drugs during the last admission were opioid analgesics (63%), followed by antibiotics (58%) and antacids (53%). On the day of death, common medications were antibiotics (59%), antacids (58%), and opioid analgesics (46%). Intravenous injection was given to 81% of the patients and intramuscular injection was given to 16% of the patients on the day of patient's death. Number of medications prescribed to patients was between 0 and 11 (median: 3) and 12% (10/81) of the patients took over 8 medications including intravenous and oral drugs on the day of death. 6% (5/81) of the patients took potentially futile medications, like multivitamin or statin until the day of death. Conclusion: This study suggests that potentially futile medications and uncomfortable care were given to terminal cancer patients. Multicenter-based studies are necessary to diminish futile medications by essential medication at the end of life care for terminal cancer patients.
Keywords
Neoplasms; Medication therapy management; Medical futility;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Curtis EB, Walsh TD. Prescribing practices of a palliative care service. J Pain Symptom Manage 1993;8:312-6.   DOI   ScienceOn
2 McPherson ML. Performing a medication regimen review in hospice and palliative care. Am J Hosp Palliat Care 2001;18:193-9.   DOI   ScienceOn
3 Vollrath AM, Sinclair C, Hallenbeck J. Discontinuing cardiovascular medications at the end of life: lipid-lowering agents. J Palliat Med 2005;8:876-81.   DOI   ScienceOn
4 Riechelmann RP, Krzyzanowska MK, O'Carroll A, Zimmermann C. Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer 2007;15:1407-12.   DOI   ScienceOn
5 Chen LK, Chou YC, Hsu PS, Tsai ST, Hwang SJ, Wu BY, et al. Antibiotic prescription for fever episodes in hospice patients. Support Care Cancer 2002;10:538-41.   DOI   ScienceOn
6 Reinbolt RE, Shenk AM, White PH, Navari RM. Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 2005;30:175-82.   DOI   ScienceOn
7 Shin HR, Jung KW, Won YJ, Kong HJ, Yim SH, Sung J, et al. National cancer incidence for the year 2002 in Korea. Cancer Res Treat 2007;39:139-49.   DOI   ScienceOn
8 Koh SJ, Lee KS, Hong YS, Yoo YS, Park HJ. Clinical change of terminally ill cancer patients at the end-of-life time. Korean J Hosp Palliat Care 2008;11:99-105.   과학기술학회마을
9 Yennurajalingam S, Zhang T, Bruera E. The impact of the palliative care mobile team on symptom assessment and medication profiles in patients admitted to a comprehensive cancer center. Support Care Cancer 2007;15:471-5.   DOI   ScienceOn
10 De Lima L. International Association for Hospice and Palliative Care list of essential medicines for palliative care. Ann Oncol 2007;18:395-9.
11 De Lima L, Doyle D. The International Association for Hospice and Palliative Care list of essential medicines for palliative care. J Pain Palliat Care Pharmacother 2007;21:29-36.   DOI   ScienceOn
12 Riechelmann RP, Krzyzanowska MK, Zimmermann C. Futile medication use in terminally ill cancer patients. Support Care Cancer 2009;17:745-8.   DOI   ScienceOn
13 Riechelmann RP, Moreira F, Smaletz O, Saad ED. Potential for drug interactions in hospitalized cancer patients. Cancer Chemother Pharmacol 2005;56:286-90.   DOI   ScienceOn
14 Nauck F, Ostgathe C, Klaschik E, Bausewein C, Fuchs M, Lindena G, et al. Drugs in palliative care: results from a representative survey in Germany. Palliat Med 2004;18:100-7.   DOI   ScienceOn
15 Fahlman C, Lynn J, Finch M, Doberman D, Gabel J. Potentially inappropriate medication use by Medicaid+Choice beneficiaries in the last year of life. J Palliat Med 2007;10:686-95.   DOI   ScienceOn
16 Oh DY, Kim JH, Kim DW, Im SA, Kim TY, Heo DS, et al. Antibiotic use during the last days of life in cancer patients. Eur J Cancer Care 2006;15:74-9.   DOI   ScienceOn